These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14695402)

  • 1. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
    Wilson MW; Kerlan RK; Fidelman NA; Venook AP; LaBerge JM; Koda J; Gordon RL
    Radiology; 2004 Jan; 230(1):287-93. PubMed ID: 14695402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.
    Lencioni R; Crocetti L; Petruzzi P; Vignali C; Bozzi E; Della Pina C; Bargellini I; Cioni D; Oliveri F; De Simone P; Bartolozzi C; Brunetto M; Filipponi F
    J Hepatol; 2008 Aug; 49(2):217-22. PubMed ID: 18486261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells.
    Toita R; Murata M; Abe K; Narahara S; Piao JS; Kang JH; Hashizume M
    Chem Commun (Camb); 2013 Aug; 49(67):7442-4. PubMed ID: 23860596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.
    Solorio L; Wu H; Hernandez C; Gangolli M; Exner AA
    Ther Deliv; 2016; 7(4):201-12. PubMed ID: 27010983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systems.
    Dubbelboer IR; Lilienberg E; Ahnfelt E; Sjögren E; Axén N; Lennernäs H
    Ther Deliv; 2014 Apr; 5(4):447-66. PubMed ID: 24856170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.
    Schmidinger M; Wenzel C; Locker GJ; Muehlbacher F; Steininger R; Gnant M; Crevenna R; Budinsky AC
    Br J Cancer; 2001 Dec; 85(12):1850-2. PubMed ID: 11747325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
    Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
    J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
    Maeng JH; Lee DH; Jung KH; Bae YH; Park IS; Jeong S; Jeon YS; Shim CK; Kim W; Kim J; Lee J; Lee YM; Kim JH; Kim WH; Hong SS
    Biomaterials; 2010 Jun; 31(18):4995-5006. PubMed ID: 20347138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead.
    Pomoni M; Malagari K; Moschouris H; Spyridopoulos TN; Dourakis S; Kornezos J; Kelekis A; Thanos L; Chatziioanou A; Hatjimarkou I; Marinis A; Koskinas J; Kelekis D
    Hepatogastroenterology; 2012 May; 59(115):820-5. PubMed ID: 22024228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC).
    Rudge S; Peterson C; Vessely C; Koda J; Stevens S; Catterall L
    J Control Release; 2001 Jul; 74(1-3):335-40. PubMed ID: 11489515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry.
    Martin RC; Rustein L; Pérez Enguix D; Palmero J; Carvalheiro V; Urbano J; Valdata A; Kralj I; Bosnjakovic P; Tatum C
    J Am Coll Surg; 2011 Oct; 213(4):493-500. PubMed ID: 21856182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of arterial chemotherapy in patients with hepatocellular carcinoma--alternate administration of mitomycin C and adriamycin].
    Hirai K; Kumagai M; Kawazoe Y; Okubo K; Yamaguchi G; Miura T; Tanaka M; Nagasaki Y; Abe M; Tanikawa K
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1252-8. PubMed ID: 6096464
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
    Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
    Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules.
    Ohnishi K; Tsuchiya S; Nakayama T; Hiyama Y; Iwama S; Goto N; Takashi M; Ohtsuki T; Kono K; Nakajima Y
    Radiology; 1984 Jul; 152(1):51-5. PubMed ID: 6203138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers.
    Sun JB; Duan JH; Dai SL; Ren J; Zhang YD; Tian JS; Li Y
    Cancer Lett; 2007 Dec; 258(1):109-17. PubMed ID: 17920762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
    Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
    Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.